Statistics

Total Visits

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers108

Select a period of time:

Number of views in the range

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers28

Views

Views
December 20254
January 20261
February 20260
March 20265
April 20265
May 20263
June 202610
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Netherlands5
Brazil2
Gabon2
Mexico2
Argentina2
Burkina Faso1
Canada1
Congo1
Chile1
 

Top cities views

Views
Groningen5
Libreville2
Algiers1
Brazzaville1
Córdoba1
Dublin1
Guadalajara1
Itanhaém1
Navalcarnero1
Ouagadougou1